DOCSLIB.ORG

FII Holdings (Nifty200) (DEC 2020)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FII Holdings (Nifty200) (DEC 2020) ShareShare HoldingHolding PatternPattern UpdateUpdate Public , 15.1% DII , Promoters , 15.0% 43.4% FII , 26.5% December 2020 DhartikumarData Analyst: DhartikumarSahu (Data Sahu Analyst) [email protected] 27-Jan-2021 Jan 27, 20211 Holding Changes (Nifty) (DEC 2020) Summary: Holding Change NIFTY NIFTY - Promoter Holding NIFTY – Insurance Company Holding . Promoter holding share in Nifty index decreased by 1.5% in . Insurance Companies holding share in Nifty index decreased Dec 20 on QoQ basis. by 0.1% in Dec 20 on QoQ basis . Promoters of Tata Motors, Grassim, NTPC, Adani Ports & . Insurance companies increased their holdings in Gail India, Ultratech Cement increased their holding by 0.54%, 0.5%, UPL, Indusind Bank, IOCL & ONGC by 0.79%, 0.73%, 0.64%, 0.09%, 0.08% & 0.06% on QoQ basis 0.49% & 0.44% on QoQ basis. Promoters decreased their holdings in Dr. Reddy’s, HDFC Life, . Insurance companies decreased their holdings in M&M, Axis Bank, Sun Pharma & M&M by 4.39%, 1.53%, 0.84%, Grasim, Dr. Reddy’s, Hindalco & Bajaj Auto by 2.2%, 1.77%, 0.21% & 0.13% on QoQ basis. 1.76%, 1.75% & 1.16% on QoQ basis. NIFTY - Mutual Fund Holdings NIFTY - DII Holdings . Mutual Fund holding share in Nifty index decreased by 0.1% in Dec 20 on QoQ basis. Domestic Institutional Investors (DII) holding share in Nifty . Mutual Fund houses increased their holdings in HCL Tech, index increased by 0.3% in Dec 20 on QoQ basis Maruti, Sun Pharma, Bajaj Auto & Coal India by 0.63%, 0.32%, . Domestic Investor (DII) increased their holdings in Sun 0.29%, 0.12% & 0.11% on QoQ basis. Pharma, JSW Steel, Coal India, UPL & ONGC by 0.45%, 0.44%, . Mutual Fund houses decreased their holdings in Tata Steel, 0.24%, 0.24% & 0.18% on QoQ basis. L&T, KMB, Indusind Bank & NTPC by 3.05%, 1.72%, 1.7%, . Domestic Investor (DII) decreased their holdings in Tata Steel, 1.67% & 1.65% on QoQ basis. Hindalco, Hero Motocorp, M&M & L&T by 4.09%, 3.23%, 2.7%, 2.46% & 2.37% on QoQ basis. NIFTY – FII Holding . Foreign Institutional Investors (FII) holding share in Nifty index decreased by 1.6% in Dec 20 on QoQ basis. Foreign Investor (FII) increased their holdings in Tata Steel, Hindalco, L&T, M&M & Indusind Bank by 5.46%, 3.41%, 3.22%, 3.19% & 3.13% on QoQ basis. FII decreased their holdings in Dr. Reddy’s, UPL, Coal India, Bajaj Auto & BPCL by 5.3%, 1.96%, 0.7%, 0.5% & 0.42% on QoQ basis. Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 2 Promoter Holding (Nifty) (DEC 2020) NIFTY - Promoter Holding Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 47,743,283 43.7% 40,746,546 45.2% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % TATA MOTORS LTD 47.89 47.35 0.54 GRASIM INDUSTRIES LTD 42.22 41.72 0.50 NTPC LTD 51.11 51.02 0.09 ADANI PORTS AND SPECIAL ECON 63.74 63.66 0.08 ULTRATECH CEMENT LTD 60.30 60.24 0.06 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % DR. REDDY'S LABORATORIES 26.74 31.13 (4.39) HDFC LIFE INSURANCE CO LTD 58.88 60.41 (1.53) AXIS BANK LTD 13.94 14.78 (0.84) SUN PHARMACEUTICAL INDUS 54.48 54.69 (0.21) MAHINDRA & MAHINDRA LTD 19.45 19.58 (0.13) For details on all stocks in the index refer page No.13 & 14 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 3 Mutual Fund Holding (Nifty) (DEC 2020) NIFTY - Mutual Fund Holdings Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 9,309,730 8.5% 7,793,635 8.6% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % HCL TECHNOLOGIES LTD 6.61 5.98 0.63 MARUTI SUZUKI INDIA LTD 7.84 7.52 0.32 SUN PHARMACEUTICAL INDUS 11.00 10.71 0.29 BAJAJ AUTO LTD 3.09 2.97 0.12 COAL INDIA LTD 9.47 9.36 0.11 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % TATA STEEL LTD 10.14 13.19 (3.05) LARSEN & TOUBRO LTD 14.86 16.58 (1.72) KOTAK MAHINDRA BANK LTD 7.59 9.29 (1.70) INDUSIND BANK LTD 9.44 11.11 (1.67) NTPC LTD 18.43 20.08 (1.65) For details on all stocks in the index refer page No.15 & 16 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 4 FII Holding (Nifty) (DEC 2020) NIFTY - FII's Holdings Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 28,767,135 26.3% 22,307,471 24.7% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % TATA STEEL LTD 17.02 11.56 5.46 HINDALCO INDUSTRIES LTD 24.27 20.86 3.41 LARSEN & TOUBRO LTD 21.12 17.90 3.22 MAHINDRA & MAHINDRA LTD 37.91 34.72 3.19 INDUSIND BANK LTD 54.94 51.81 3.13 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % DR. REDDY'S LABORATORIES 29.14 34.44 (5.30) UPL LTD 38.54 40.50 (1.96) COAL INDIA LTD 6.50 7.20 (0.70) BAJAJ AUTO LTD 13.07 13.57 (0.50) BHARAT PETROLEUM CORP LTD 11.57 11.99 (0.42) For details on all stocks in the index refer page No.17 & 18 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 5 Insurance Companies Holding (Nifty) (DEC 2020) (NIFTY)Insurance Comp Holdings Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 6,992,274 6.4% 5,889,623 6.5% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % GAIL INDIA LTD 9.98 9.19 0.79 UPL LTD 11.86 11.13 0.73 INDUSIND BANK LTD 6.67 6.03 0.64 INDIAN OIL CORP LTD 8.06 7.57 0.49 OIL & NATURAL GAS CORP LTD 11.77 11.33 0.44 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % MAHINDRA & MAHINDRA LTD 10.75 12.95 (2.20) GRASIM INDUSTRIES LTD 11.70 13.47 (1.77) DR. REDDY'S LABORATORIES 1.00 2.76 (1.76) HINDALCO INDUSTRIES LTD 9.96 11.71 (1.75) BAJAJ AUTO LTD 6.03 7.19 (1.16) For details on all stocks in the index refer page No.19 & 20 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 6 DII Holding (Nifty) (DEC 2020) NIFTY - DII's Holdings Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 16,776,730 15.4% 14,118,215 15.7% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % SUN PHARMACEUTICAL INDUS 20.67 20.22 0.45 JSW STEEL LTD 6.29 5.85 0.44 COAL INDIA LTD 22.15 21.91 0.24 UPL LTD 17.29 17.05 0.24 OIL & NATURAL GAS CORP LTD 17.72 17.54 0.18 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % TATA STEEL LTD 25.96 30.05 (4.09) HINDALCO INDUSTRIES LTD 23.51 26.74 (3.23) HERO MOTOCORP LTD 14.60 17.30 (2.70) MAHINDRA & MAHINDRA LTD 21.69 24.15 (2.46) LARSEN & TOUBRO LTD 33.07 35.44 (2.37) For details on all stocks in the index refer page No.21 & 22 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 7 Promoter Holdings (Nifty200) (DEC 2020) CNX200 - Promoter Holding Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 76,335,478 48.5% 64,131,903 49.5% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % Indus Towers Ltd 69.85 53.52 16.33 Tata Chemicals Ltd 37.98 35.47 2.51 Godrej Industries Ltd 66.38 64.97 1.41 Nippon Life India Asset Mana 75.82 74.95 0.87 Tata Motors Ltd 47.89 47.35 0.54 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % Indian Railway Catering & To 67.40 87.40 (20.00) Canara Bank 69.34 78.55 (9.21) Crompton Greaves Consumer El 17.43 26.20 (8.77) Punjab National Bank 76.87 85.59 (8.72) Mindtree Ltd 61.03 67.59 (6.56) For details on all stocks in the index refer page No.23 & 24 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 8 Mutual Fund Holdings (Nifty200) (DEC 2020) CNX200 - Mutual Fund Holding Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 12,449,532 7.9% 10,535,698 8.1% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % Lic Housing Finance Ltd 9.62 4.49 5.13 Federal Bank Ltd 29.91 25.03 4.88 Indian Railway Catering & To 5.04 0.97 4.07 Coforge Limited 10.00 6.73 3.27 Crompton Greaves Consumer El 27.69 24.76 2.93 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % Tata Chemicals Ltd 12.04 16.79 (4.75) Trent Ltd 6.16 10.67 (4.51) Pi Industries Ltd 16.20 20.56 (4.36) Balkrishna Industries Ltd 14.96 18.97 (4.01) Acc Ltd 9.58 12.77 (3.19) For details on all stocks in the index refer page No.25 - 27 Source: BSE, ACE Equity,Bloomberg Data Analyst: Dhartikumar Sahu [email protected] 27-Jan-2021 9 FII Holdings (Nifty200) (DEC 2020) CNX200 - FII's Holdings Share in Index Mkt_Cap Dec'20 Sept'20 Dec'20 Sept'20 % holding in % holding in (Rs mn) (Rs mn) index index 36,846,156 23.4% 28,548,639 22.0% TOP 5 Increase in Holding % Company Dec-20 Sep-20 QoQ Chng % Indian Railway Catering & To 8.39 0.88 7.51 Rbl Bank Ltd 35.18 27.80 7.38 Trent Ltd 29.41 23.13 6.28 Ipca Laboratories Ltd 18.23 12.41 5.82 Tata Steel Ltd 17.02 11.56 5.46 TOP 5 Dip in Holding % Company Dec-20 Sep-20 QoQ Chng % Indus Towers Ltd 26.64 40.90 (14.26) Max Financial Services Ltd 19.70 32.40 (12.70) Godrej Agrovet Ltd 3.15 15.36 (12.21) Dr.
Load more

Recommended publications
  • Replacements in Indices
    Date: February 21, 2018 PRESS RELEASE Replacements in Indices The Index Maintenance Sub-Committee (IMSC) has decided to make the following replacement of stocks in various indices as part of its periodic review. These changes shall become effective from April 02, 2018 (close of March 28, 2018). 1) NIFTY 50 The following companies are being excluded: Sr. No. Company Name Symbol 1 Ambuja Cements Ltd. AMBUJACEM 2 Aurobindo Pharma Ltd. AUROPHARMA 3 Bosch Ltd. BOSCHLTD The following companies are being included: Sr. No. Company Name Symbol 1 Bajaj Finserv Ltd. BAJAJFINSV 2 Grasim Industries Ltd. GRASIM 3 Titan Company Ltd. TITAN The above replacements will also be applicable to NIFTY50 Equal Weight Index. 2) NIFTY Next 50 The following companies are being excluded: Sr. No. Company Name Symbol 1 Bajaj Finserv Ltd. BAJAJFINSV 2 GlaxoSmithkline Consumer Healthcare Ltd. GSKCONS 3 Glaxosmithkline Pharmaceuticals Ltd. GLAXO 4 Glenmark Pharmaceuticals Ltd. GLENMARK 5 Tata Power Co. Ltd. TATAPOWER 6 Titan Company Ltd. TITAN 7 Torrent Pharmaceuticals Ltd. TORNTPHARM The following companies are being included: Sr. No. Company Name Symbol 1 Aditya Birla Capital Ltd. ABCAPITAL Sr. No. Company Name Symbol 2 Ambuja Cements Ltd. AMBUJACEM 3 Aurobindo Pharma Ltd. AUROPHARMA 4 Bosch Ltd. BOSCHLTD 5 General Insurance Corporation of India GICRE 6 L&T Finance Holdings Ltd. L&TFH 7 SBI Life Insurance Company Ltd. SBILIFE 3) NIFTY 500 The following companies are being excluded: Sr. No. Company Name Symbol 1 Adani Enterprises Ltd. ADANIENT 2 Ahluwalia Contracts (India) Ltd. AHLUCONT 3 Apar Industries Ltd. APARINDS 4 AstraZenca Pharma India Ltd. ASTRAZEN 5 Corporation Bank CORPBANK 6 Dalmia Bharat Ltd.
    [Show full text]
  • Quarterly Shareholder Update Q 1 January - 31 March 2020 1
    Pacific Assets Trust plc Quarterly Shareholder Update Q 1 January - 31 March 2020 1 Image location: Mumbai This document is a financial promotion for Pacific Assets Trust plc (the “Trust”) only for those people resident in the UK for tax and investment purposes. Investing involves certain risks including: • The value of investments and any income from them may go down as well as up and are not guaranteed. Investors may get back significantly less than the original amount invested. • Emerging market risk: emerging markets may not provide the same level of investor protection as a developed market; they may involve a higher risk than investing in developed markets. • Currency risk: the Trust invests in assets which are denominated in currencies other than pound sterling; changes in exchange rates will affect the value of the Trust. • The Trust’s share price may not fully reflect net asset value. Reference to specific securities (if any) is included for the purpose of illustration only and should not be construed as a recommendation to buy or sell. Reference to the names of any company is merely to explain the investment strategy and should not be construed as investment advice or a recommendation to invest in any of those companies. For an overview of the terms of investment, risks, returns and costs and charges please refer to the Key Information Document which can be found on the Trust’s website: www.pacific-assets.co.uk. If you are in any doubt as to the suitability of the Trust for your investment needs, please seek investment advice.
    [Show full text]
  • 50 KW Offer Solar Copy 2
    21st Century Enviro Engineers Pvt.Ltd. Plot No. 120(10 Marla), COMPANY Industrial Area Phase II Chandigarh - 160002, India PROFILE www.21stcenturyenviro.com INTRODUCTION 21st CENTURY ENVIRO ENGINEERS PVT. LTD. is a Company dealing in the field of Environmental Engineering related activities. We are Registered Environmental Consultants of Pollution Control Board to Supply ETP’s, STP’s, APCD’s, Incinerators, Water Treatment Plants, Reverse Osmosis, Evaporators, Solid Waste Management and Rain Water Harvesting and to carry out EIA Studies . The Directors of the company are young Technocrats having versatile experience in this field. We have a back up of highly qualified and experienced technical team having versatile experience in Designing, Erection, Commissioning and Operation of different types of Effluent Treatment Plants. Our Managing Director himself is a Chemical Engineer with almost 25 Years Experience in this line and Technical Director is PhD. in Environmental Science with almost 30 Years working experience on various types of effluent treatment Technologies. Our team comprises of almost 150 people from different backgrounds e.g. Chemical, Environmental, Mechanical, Instrumentation, Civil, Accounts, Purchase, Marketing etc. We have our Marketing/ Design Office in Chandigarh and regional offices in Dhaka, Mumbai, New Delhi, Sikkim etc. and have our own testing Laboratory for Effluent/Water Testing and to study treatability of effluent on pilot scale. We have our own full-fledged manufacturing unit of Pollution Control Equipments in Village Kunjhal Baddi (HP). We also undertake annual operation and maintenance contracts and liasining services for the systems supplied by us. We are also Registered with CREST (Chandigarh Renewable Energy & Technology Promotion Society) and SECI (Solar Energy Corporation of India) for supplying Online/Offline Solar systems in Chandigarh, Himachal Pradesh, Uttarakhand, J&K, Punjab, Haryana, Delhi, Bihar etc.
    [Show full text]
  • Morning Note Market Snapshot
    Morning Note Market Snapshot October 12, 2020 Market Snapshot (Updated at 8AM)* Key Contents Indian Indices Close Net Chng. Chng. (%) Market Outlook/Recommendation Sensex 40509.49 326.82 0.81 Today’s Highlights Nifty 11914.20 79.60 0.67 Global News, Views and Updates Global Indices Close Net Chng. Chng. (%) Links to important News highlight DOW JONES 28586.90 161.39 0.57 Top News for Today NASDAQ COM. 11579.94 158.96 1.39 FTSE 100 6016.65 38.62 0.65 Vedanta: The company on Saturday said that the delisting offer is deemed to have failed as per terms of the delisting regulations. The post offer public CAC 40 4946.81 34.87 0.71 announcement by the company said that 125.47 crore shares were validly DAX 13051.23 9.02 0.07 tendered by public shareholders. NIKKEI 225 23573.55 41.51 0.18 Federal-Mogul Goetze (India): Promoter IEH FMGI Holdings to sell up to 1.21 SHANGHAI 3314.68 43.00 1.31 crore shares or 21.83% stake through an Offer for Sale (OFS). The floor price of Rs 342 per share is a 21.1% discount to Friday's closing price. HANG SENG 24496.08 357.47 1.48 Glenmark: The company said that addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients. Currency Close Net Chng. Chng. (%) Indiabulls Housing Finance: Has sold further portion of its stake in OakNorth USD / INR 73.13 0.11 0.15 Holding - the wholly-owning parent company of OakNorth Bank to Riva Capital USD / EUR 1.18 0.00 0.06 Partners for approximately Rs 441 crore.
    [Show full text]
  • Index Stock Update >> Marico Stock Update >> Gabriel India Stock Update >> PTC India Stock
    Visit us at www.sharekhan.com November 04, 2015 Index Stock Update >> Marico Stock Update >> Gabriel India Stock Update >> PTC India Stock Update >> Ipca Laboratories Stock Update >> Skipper Viewpoint >> Lloyd Electric & Engineering For Private Circulation only REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai – 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/ INF231073330 ; CD-INE231073330 ; MSEI - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS- INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX- 00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at [email protected] ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do’s & Don’ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. investor’s eye stock update Marico Reco: Buy Stock Update Enhanced focus to improve volume growth; maintain Buy CMP: Rs399 Company details Key points Price target: Rs460 Mixed operating performance: During Q2FY2016, Marico’s revenue grew by 4% to Rs1,485.4 crore, entirely driven by a 4% volume growth (domestic business’ volume Market cap: Rs25,735 cr growth stood at 5.5%). The gross profit margin (GPM) improved by almost 500BPS to 52 week high/low: Rs466/299 49.3% on the back of ~30% decline in the copra prices and 33% decline in the prices of liquid paraffin.
    [Show full text]
  • Pan India Tie up with Dr Lal Pathlabs for Pathology Services and Delhi Ncr
    HUMAN RESOURCES MANAGEMENT DIVISION, HOSPITALISATION CELL CORPORATE OFFICE- DWARKA-NEW DELHI (PHONE [email protected]) Date: 03.05.2014 TO ALL OFFICES: HRMD CIRCULAR NO. 409 REG: PAN INDIA TIE UP WITH DR.LAL PATHLABS FOR PATHOLOGY SERVICES AND DELHI NCR NETWORK FOR RADIOLOGY SERVICES The Bank has been making efforts to have tie up arrangement with reputed hospitals/Diagnostic Centers for charging rates for OPD Consultation, lab charges and General/Executive Health Check-up of employees and Indoor facilities on reimbursement basis. Dr Lal Path Labs runs Asia’s biggest National Reference Lab testing more than 10,000 patients’ samples every day at New Delhi and runs another 100 state-of- the-art satellite laboratories, 75 Patient Service Centers and about 1500 collection centers all over India and overseas, carry out sophisticated tests and has a highly qualified dedicated team. We are pleased to inform that Bank has taken up with Dr LAL Path lab for discounts to PNB staff including retirees and in context after detailed discussion they have agreed to provide following services to PNB employees and retirees on PAN India basis:- 20% Cash Rate discount for all serving and retired employees of PNB and their dependents on PAN India network of Dr. Lal Path Lab for pathology services and on Delhi NCR network for Radiology services Checkups can be done at our Pan India Company owned Satellite Lab’s and PSC’s as per list attached. Employee can avail home collection service by paying Rs.100 extra/per visit (DNCR Only). Payment: Payment shall be made by employee at the time registration.
    [Show full text]
  • Inner 25 India Pharma & Healthcare Fund
    Modera erate tely Mod High to e H w at ig o er h L d o M V e r y w H Tata India Pharma & Healthcare Fund o i L g (An open ended equity scheme investing in Pharma and Healthcare Services Sector) h Riskometer Investors understand that their principal As on 30th June 2021 PORTFOLIO will be at Very High Risk INVESTMENT STYLE Company name No. of Market Value % of Company name No. of Market Value % of Primarily focuses on investment in at least 80% of its net Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India. Equity & Equity Related Total 55184.24 97.88 Glenmark Pharmaceuticals Ltd. 167000 1089.76 1.93 INVESTMENT OBJECTIVE Healthcare Services Sanofi India Ltd. 13000 997.39 1.77 The investment objective of the scheme is to seek long Apollo Hospitals Enterprise Ltd. 70500 2551.99 4.53 Gland Pharma Ltd. 19662 673.29 1.19 term capital appreciation by investing atleast 80% of its Fortis Healthcare Ltd. 795000 1935.03 3.43 Laurus Labs Ltd. 90000 619.79 1.10 net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in Syngene International Ltd. 265000 1545.75 2.74 India.However, there is no assurance or guarantee that the investment objective of the Scheme will be Narayana Hrudayalaya Ltd. 301420 1483.74 2.63 Other Equities^ 1186.14 2.10 achieved.The Scheme does not assure or guarantee any Metropolis Healthcare Ltd.
    [Show full text]
  • Ipca Laboratories (IPCLAB)
    Ipca Laboratories (IPCLAB) CMP: | 2040 Target: | 2290 (12%) Target Period: 12 months HOLD May 31, 2021 Upbeat guidance, execution remains key Q4 revenues remained subdued growing just 3.8% YoY to | 1115 crore. Strong YoY growth of 19.7% in export formulations to | 338 crore was partly Particulars offset by API sales decline of 5.5% YoY to | 260 crore. Domestic Particular Amount formulations remained flat at | 434 crore vs. | 431 crore in Q4FY20. EBITDA Market Capitalisation | 25873 crore margins improved 484 bps YoY to 20.5% due to better gross margins and Debt (FY21) | 267 crore lower other expenditure. EBITDA grew 35.8% YoY to | 229 crore. PAT grew Cash (FY21) | 365 crore 87.5% YoY to | 161 crore (I-direct estimate: | 204 crore). Delta vis-à-vis EV | 25775 crore EBITDA was due to higher other income, lower depreciation and tax rate. 52 week H/L (|) 2456/1467 Equity capital | 25.4 crore Update Result Export formulations main catalyst for growth Face value | 2 Price performance Growth in export formulations (29% of FY21 revenues) was on the back of growth in both international generics and international branded 2500 14000 formulations. The international anti-malarial institutional business has also 12000 2000 contributed substantially to overall exports growth. US traction will take 10000 longer than earlier estimated due to USFDA import alerts for the Ratlam 1500 8000 facility that is the only API source for Silvassa and Pithampur formulations 1000 6000 plants along with Silvassa and Pithampur (Indore) plants that are specifically 4000 500 earmarked for the US business, besides third party sales.
    [Show full text]
  • Final Placement Report 2016-2018
    INDIAN INSTITUTE OF Final Placement Report MANAGEMENT 2016-2018 INDORE OVERVIEW It gives me immense pleasure overseeing a successful placement season with a tremendous increase in the average CTC as well as the highest CTC. Leveraging upon the largest batch across all IIMs -including PGP, PGP Mumbai and IPM programmes, an advent of new relationships were developed. This is a testament to the confidence and trust shown by the industry in the rigor and excellence of IIM Indore and further reaffirms our position among the top business schools in the country. On behalf of the entire IIM Indore Community, I would like to thank all our recruitment partners for continuous support and for recognizing IIM Indore as a preferred campus for recruitment. - Prof. Rishikesha T. Krishnan, Director IIM Indore has once again proven its eminence among the premier business schools of the country with the recently concluded final placements for 2016-18 batch that comprised of 624 participants (443 PGP, 68 PGP- Mumbai & 113 IPM). The multitude of offers granted by industry giants reaffirms their trust in the institute and its legacy. The season witnessed a highly commendable increase in the number of recruiters across multiple sectors. More than 200 recruiters participated in the process. The highest international package offered this year was 63.45 LPA while the highest domestic package stood at 33.04 LPA. The average CTC for the batch was 18.17 LPA, which is a 12% increase from the previous year. Also, owing to the excellent performance of students during their summer internships, the number of Pre-Placement Offers (PPOs) extended by companies this year increased by an astonishing 40% to 147.
    [Show full text]
  • Pharma Sector Report -Sept’20
    Mutual Fund: Pharma Sector Report -Sept’20 Private & confidential. Only for limited circulation. Contact us: [email protected] Executive Summary: Since the outbreak of the Coronavirus crisis, the pharma sector stepped into the spotlight. Long overdue investments have been flowing towards the sector and even pharma funds in the mutual fund industry have begun to outperform. Nevertheless, there is still a clear need for government spending in this sector. Compared to the US, which has the highest per capita spending on healthcare at $5000, India spends merely ~ $50 per capita. The current situation presents the Indian government with a perfect opportunity to increase its expenditure in this sector, to facilitate its growth and fast-track its progress. Few points about the Pharma Funds: The market capitalization of the entire pharma & healthcare industry is ~ Rs. 10 lac crs, whereas the total size of pharma funds in the mutual fund is ~Rs. 10k crs, translating to ~ 1% of the entire sector in value terms. (This excludes the pharma holdings in other categories). There are 43 pharma & healthcare companies that form part of the Top 500 companies. Out of these, pharma funds have an exposure to 36 companies. There are 11 companies in the Top 100; 11 in the Midcap space (101-250) and 14 Smallcaps (251-500). The 7 companies that do not form part of the pharma funds’ portfolios are Caplin Point Lab, Glenmark Pharma, Granules India, Piramal Enterprises, Poly Medicure, Suven Pharma and Wockhardt Ltd. Cipla Ltd., Divis Laboratories Ltd. and Dr. Reddy’s Laboratories Ltd. are the only stocks that form part of every pharma fund.
    [Show full text]
  • List of 3Rd Party Manufacturer of Pre-Qualified/Registered Firms with PPT Hospital
    List of 3rd party Manufacturer of Pre-qualified/Registered Firms with PPT Hospital SL. Name of the Parent Firm Name of the 3rd party manufacturer NO A B C 1 M/s AKUMENTIS HEALTHCARE LTD. (i) M/S Unimark Healthcare Ltd (ii) M/S Applied Communication & Controls (iii) Maxcure Nutravedics Ltd (iv) Akums Drugs & Pharmaceuticals Ltd 2 M/s ALCON LABORATORIES(INDIA)PVT.LTD (i) M/S Wintac Limited 3 M/s ABBOTT HEALTHCARE PVT. LTD. (i) Akums Drugs & Pharmaceuticals Ltd (ii) Medibios Laboratories Pvt. Ltd. (iii) Tristar Formulations Pvt. Ltd. (iv) Hetero Labs Ltd (v) M/S Aqua Vitoe Laboratories 4 M/s ABBOTT INDIA LIMITED. (i) Acme Formulation Pvt Ltd (ii) Revenbhel Healthcare Pvt. Ltd. 5 M/s CENTAUR PHARMACEUTICALS PVT. LTD. (i) M/S Pure & Cure Healthcare Pvt. Ltd. (ii) M/S The Madras Pharmaceuticals (iii) M/S Akums Drugs & Pharmaceuticals Limited 6 M/S CIPLA LIMITED (i) Akums Drugs & Pharmaceuticals Ltd (ii) BDR Pharmaceuticals International Pvt. Ltd. (iii) M/S Medispray Laboratories Pvt. Ltd. (iv) M/S Golden Cross Pharma Pvt. Ltd. (v) M/S Tirupati Medicare Limited (vi) M/S Mepromax Lifesciences PVT Ltd. (vii) M/S Virchow Biotech Private Limited (viii) Hetero Labs Ltd (ix) Pegasus Farmaco Iindia Pvt. Ltd. (x) Meditab Specialities Pvt. Ltd. 7 M/s DR. REDDYS LABORATORIES LTD (i) Bdr Pharmaceuticals Ltd (ii) Naprod Lifesciences Pvt. Ltd (iii) Hetero Labs Ltd (iv) Natco Pharma Ltd (v) Amgen Manufacturing Limited 8 M/s FOURRTS (INDIA) LABORATORIES PVT. (i) M/S Swiss Garnier Biotech (ii) M/S Sun Glow Pharmaceuticals Private Limited 9 M/s GLOBUS REMEDIES (i) Park Pharmaceuticals (ii) Baxil Pharma Pvt.
    [Show full text]
  • Weights for New Portfolio of India Small Cap Index (ISCIN) - As on March 12, 2013 S No Ticker Name ISIN SEDOL Weights 1 FB in Equity Federal Bank Ltd
    Weights for New Portfolio of India Small Cap Index (ISCIN) - As on March 12, 2013 S No Ticker Name ISIN SEDOL Weights 1 FB IN Equity Federal Bank Ltd. INE171A01011 6139845 4.00% 2 APHS IN Equity Apollo Hospitals Enterprise Ltd. INE437A01024 6273583 3.52% 3 ABNL IN Equity Aditya Birla Nuvo Ltd. INE069A01017 6100421 3.43% 4 TTCH IN Equity Tata Chemicals Ltd. INE092A01019 6101167 3.26% 5 MMFS IN Equity Mahindra & Mahindra Financial Services Ltd. INE774D01024 B8F8822 3.25% 6 TGBL IN Equity Tata Global Beverages Ltd. INE192A01025 6121488 3.09% 7 HPCL IN Equity Hindustan Petroleum Corp. Ltd. INE094A01015 6100476 2.95% 8 EXID IN Equity Exide Industries Ltd. INE302A01020 B1D3ZC9 2.86% 9 RCAPT IN Equity Reliance Capital Ltd. INE013A01015 6101082 2.44% 10 UNTP IN Equity United Phosphorus Ltd. INE628A01036 B0L0W35 2.32% 11 PLNG IN Equity Petronet LNG Ltd. INE347G01014 B00KT68 2.24% 12 AL IN Equity Ashok Leyland Ltd. INE208A01029 B01NFT1 2.20% 13 UT IN Equity Unitech Ltd. INE694A01020 B17MRV5 2.14% 14 CRG IN Equity Crompton Greaves Ltd. INE067A01029 B1B90H9 2.08% 15 OBC IN Equity Oriental Bank of Commerce INE141A01014 6121507 2.01% 16 IPCA IN Equity IPCA Laboratories Ltd. INE571A01020 6433473 1.96% 17 JUBI IN Equity Jubilant FoodWorks Ltd. INE797F01012 B3PRM66 1.94% 18 MRF IN Equity MRF Ltd. INE883A01011 6214128 1.88% 19 ALBK IN Equity Allahabad Bank INE428A01015 6708289 1.85% 20 STR IN Equity Strides Arcolab Ltd. INE939A01011 6690535 1.84% 21 DITV IN Equity Dish TV India Ltd. INE836F01026 B1RMW32 1.78% 22 JKBK IN Equity Jammu & Kashmir Bank Ltd.
    [Show full text]